当前位置： SCI文献检索 > Pituitary期刊下所有文献 > Characterization of the ability of a, second-generation SST-DA chimeric molecule, TBR-065, to suppress GH secretion from human GH-secreting adenoma cells.

Characterization of the ability of a, second-generation SST-DA chimeric molecule, TBR-065, to suppress GH secretion from human GH-secreting adenoma cells.

Abstract：

CONTEXT:Somatostatin (SST) and dopamine (DA) inhibit growth hormone (GH) secretion and proliferation of GH-secreting pituitary adenomas (GHomas) through binding to SSTR2 and D2R receptors. Chimeric SST-DA compounds (Dopastatins) display increased potency in inhibiting GH secretion, as compared with individual SST or DA analogs (alone or combined). OBJECTIVE:To assess the efficacy of a second-generation dopastatin, TBR-065, in suppressing GH secretion from human GH- and GH/prolactin(PRL)-omas. DESIGN:We compared the ability of TBR-065 to inhibit GH secretion from primary cultures of human GH- or GH/PRLoma cells to that of the first generation dopastatin, TBR-760 (formerly BIM-23A760), octreotide (OCT) and cabergoline (CAB), the later either alone or combined. We investigated whether there was any impact of BIM-133, the metabolite of TBR-065, on the ability of TBR-065 to inhibit GH in these cultures. METHODS:17 GH- and GH/PRLomas were included in this study. Inhibition of GH secretion by TBR-065, TBR-760, OCT and CAB (0.1 pM to 0.1 µM) was assessed over a period of 8 h. RESULTS:All tumors expressed SSTR2 and D2R mRNAs. GH suppression was higher with TBR-065 as compared with TBR-760 (Emax = 57 ± 5.6% vs. 41.1 ± 12.5%, respectively, p < 0.001) or with OCT + CAB (Emax = 56.8 ± 7.2% vs. 44.4 ± 9.4%, p < 0.001). BIM-133 did not have any impact on the activity of TBR-065. CONCLUSION:TBR-065 has significantly improved efficacy in suppressing GH secretion as compared to current available therapies and may represent a new promising option for the treatment of acromegaly.

journal_name

Pituitary

journal_title

Pituitary

authors

Cuny T,Graillon T,Defilles C,Datta R,Zhang S,Figarella-Branger D,Dufour H,Mougel G,Brue T,Landsman T,Halem HA,Culler MD,Barlier A,Saveanu A

doi

10.1007/s11102-020-01113-4

subject

Has Abstract

pub_date

2021-01-12 00:00:00

eissn

1386-341X

issn

1573-7403

pii

10.1007/s11102-020-01113-4

pub_type

杂志文章

相关文献

Pituitary文献大全
  • Evaluation of survivin splice variants in pituitary tumors.

    abstract：PURPOSE:Survivin is an apoptosis inhibitor, expressed in almost all types of human malignancies, but rarely in differentiated normal tissues. Recently, survivin gene splice variants with different anti-apoptotic activities have been reported. The current study was undertaken to examine the expression of survivin and it...

    journal_title：Pituitary

    pub_type： 杂志文章

    doi：10.1007/s11102-014-0590-9

    authors： Waligórska-Stachura J,Andrusiewicz M,Sawicka-Gutaj N,Kubiczak M,Jankowska A,Liebert W,Czarnywojtek A,Waśko R,Blanco-Gangoo AR,Ruchała M

    更新日期：2015-06-01 00:00:00

  • Osilodrostat, a potent oral 11β-hydroxylase inhibitor: 22-week, prospective, Phase II study in Cushing's disease.

    abstract：PURPOSE:In a 10-week proof-of-concept study (LINC 1), the potent oral 11β-hydroxylase inhibitor osilodrostat (LCI699) normalized urinary free cortisol (UFC) in 11/12 patients with Cushing's disease. The current 22-week study (LINC 2; NCT01331239) further evaluated osilodrostat in patients with Cushing's disease. METHO...

    journal_title：Pituitary

    pub_type： 杂志文章,多中心研究

    doi：10.1007/s11102-015-0692-z

    authors： Fleseriu M,Pivonello R,Young J,Hamrahian AH,Molitch ME,Shimizu C,Tanaka T,Shimatsu A,White T,Hilliard A,Tian C,Sauter N,Biller BM,Bertagna X

    更新日期：2016-04-01 00:00:00

  • Pituitary xanthogranulomas: clinical features, radiological appearances and post-operative outcomes.

    abstract：BACKGROUND:Xanthogranulomas are inflammatory masses most commonly found at peripheral sites such as the skin. Sellar and parasellar xanthogranulomas are rare and present a diagnostic challenge as they are difficult to differentiate from other sellar lesions such as craniopharyngiomas and Rathke's cleft cysts pre-operat...

    journal_title：Pituitary

    pub_type： 杂志文章

    doi：10.1007/s11102-017-0859-x

    authors： Ved R,Logier N,Leach P,Davies JS,Hayhurst C

    更新日期：2018-06-01 00:00:00

  • Monotherapy with lanreotide depot for acromegaly: long-term clinical experience in a pituitary center.

    abstract：PURPOSE:Long-acting somatostatin analogs are one of the main classes of medical therapy used for acromegaly and most patients require ongoing treatment. Few studies have evaluated the long-term efficacy and safety of lanreotide depot beyond 2 years. The goal of this study was to provide a long-term longitudinal assessm...

    journal_title：Pituitary

    pub_type： 杂志文章

    doi：10.1007/s11102-016-0724-3

    authors： Sagvand BT,Khairi S,Haghshenas A,Swearingen B,Tritos NA,Miller KK,Klibanski A,Nachtigall LB

    更新日期：2016-08-01 00:00:00

  • Cushing's disease.

    abstract：:Cushing's disease, i.e., pituitary ACTH-secreting adenoma causing excess glucocorticoid secretion, is a rare disease with significant mortality and morbidity. Timely diagnosis and appropriate treatment can alter the course of the disease and are therefore mandatory. First step of the diagnostic work-up is the endogeno...

    journal_title：Pituitary

    pub_type： 杂志文章,评审

    doi：10.1007/s11102-006-0407-6

    authors： De Martin M,Pecori Giraldi F,Cavagnini F

    更新日期：2006-01-01 00:00:00

  • Pituitary tuberculosis mimicking idiopathic granulomatous hypophysitis.

    abstract：:An unusual case of tubercular granulomatous hypophysitis is reported. A sellar mass diagnosed as pituitary adenoma in MRI, showed non-caseating granulomas, glandular destruction and fibrosis in histology. Stain for acid-fast bacilli (AFB) were negative and the case was misdiagnosed as Idiopathic Granulomatous hypophys...

    journal_title：Pituitary

    pub_type： 杂志文章

    doi：10.1007/s11102-007-0068-0

    authors： Husain N,Husain M,Rao P

    更新日期：2008-01-01 00:00:00

  • Angiographically documented cerebral vasospasm following transsphenoidal surgery for pituitary tumors.

    abstract：:Symptomatic cerebral vasospasm (CVS) after transsphenoidal surgery (TSS) is very rare compared with vasospasm resulting from aneurysmal subarachnoid hemorrhage (SAH). Fewer than six cases documented by cerebral angiography have been reported. We evaluated the records of 15 patients in whom SAH developed after TSS. The...

    journal_title：Pituitary

    pub_type： 杂志文章

    doi：10.1007/s11102-012-0415-7

    authors： Kim EH,Oh MC,Kim SH

    更新日期：2013-06-01 00:00:00

  • The relationship between prolactin (PRL), leptin, nitric oxide (NO), and cytokines in patients with hyperprolactinemia.

    abstract：:Leptin is a key mediator in the maintenance of neuroendocrine homeostasis. The aim of this study was to determine the changes in serum leptin, tumor necrosis factor-alpha (TNF-alpha), interleukin-6 (IL-6), nitric oxide (NO) levels in patients with hyperprolactinemia. The study consists of 16 consecutive patients with ...

    journal_title：Pituitary

    pub_type： 杂志文章

    doi：10.1007/s11102-008-0140-4

    authors： Balci H,Akgun-Dar K,Gazioglu N,Kapucu A,Bolayirli M,Oz B

    更新日期：2009-01-01 00:00:00

  • Subclinical Cushing's syndrome.

    abstract：:Clinically inapparent adrenal masses, or adrenal incidentalomas, are discovered inadvertently in the course of workup or treatment of unrelated disorders. Cortical adenoma is the most frequent type of adrenal incidentaloma accounting for approximately 50% of cases in surgical series and even greater shares in medical ...

    journal_title：Pituitary

    pub_type： 杂志文章,评审

    doi：10.1007/s11102-005-4024-6

    authors： Terzolo M,Reimondo G,Bovio S,Angeli A

    更新日期：2004-01-01 00:00:00

  • Effective time window in reducing pituitary adenoma size by gamma knife radiosurgery.

    abstract：OBJECTIVES:Although the effectiveness of gamma knife radiosurgery (GKRS) in controlling the size of pituitary adenomas has been well demonstrated in many studies, the time period in which significant changes in tumor size occurs has been investigated in a limited fashion. It is important to determine the therapeutic wi...

    journal_title：Pituitary

    pub_type： 杂志文章

    doi：10.1007/s11102-014-0603-8

    authors： Mak HK,Lai SW,Qian W,Xu S,Tong E,Vance ML,Oldfield E,Jane J Jr,Sheehan J,Yau KK,Wintermark M

    更新日期：2015-08-01 00:00:00

  • Histopathological classification of non-functioning pituitary neuroendocrine tumors.

    abstract：:Non-functioning pituitary neuroendocrine tumors do not cause endocrine symptoms related to hypersecretion of adenohypophyseal hormones and are clinically characterized by symptoms due to growing sellar tumor mass. Histopathological classification of this tumor group has always been challenging due to their heterogenei...

    journal_title：Pituitary

    pub_type： 杂志文章,评审

    doi：10.1007/s11102-017-0855-1

    authors： Manojlovic-Gacic E,Engström BE,Casar-Borota O

    更新日期：2018-04-01 00:00:00

  • Cis-unsaturated free fatty acids block VIP-mediated GH and PRL secretion by perturbing the cAMP/protein kinase A pathway.

    abstract：:Cis-unsaturated free fatty acids (FFA) like oleic acid are strong blockers of both basal and stimulated GH secretion in vivo by acting directly on the somatotroph cell. Several lines of evidence suggest that this inhibitory action is the result of a perturbation of the function of several plasma membrane integral prot...

    journal_title：Pituitary

    pub_type： 杂志文章

    doi：10.1023/a:1009962624036

    authors： Pérez FR,Camiña JP,Menéndez C,Beiras A,Casabiell X,Casanueva FF

    更新日期：1998-04-01 00:00:00

  • Fatal inflammatory hypophysitis.

    abstract：:A young female patient presented as an acute medical emergency with hypoglycaemia. Investigations revealed panhypopituitarism and an inflammatory pituitary mass. An antibody screen was negative for anti-neutrophil cytoplasmic antibodies with cytoplasmic distribution (cANCA). Pituitary histology showed lymphocytic infi...

    journal_title：Pituitary

    pub_type： 杂志文章

    doi：10.1007/s11102-007-0016-z

    authors： McIntyre EA,Perros P

    更新日期：2007-01-01 00:00:00

  • Aerosolisation in endonasal endoscopic pituitary surgery.

    abstract：PURPOSE:To determine the particle size, concentration, airborne duration and spread during endoscopic endonasal pituitary surgery in actual patients in a theatre setting. METHODS:This observational study recruited a convenience sample of three patients. Procedures were performed in a positive pressure operating room. ...

    journal_title：Pituitary

    pub_type： 杂志文章

    doi：10.1007/s11102-021-01125-8

    authors： Dhillon RS,Nguyen LV,Rowin WA,Humphries RS,Kevin K,Ward JD,Yule A,Phan TD,Zhao YC,Wynne D,McNeill PM,Hutchins N,Scott DA

    更新日期：2021-01-19 00:00:00

  • Be careful... She has a pituitary gland in her nose.

    abstract：:In this case report we describe a 38 year-old-female with galactorrhea several months after the birth of an anencephalic child. She had hyperpolactemia and imaging of the pituitary gland revealed a midline defect and a nasopharyngeal mass compatible with a meningo-(hypophyso-) encephalocele and possibly an ectopic ter...

    journal_title：Pituitary

    pub_type： 杂志文章

    doi：10.1007/s11102-011-0320-5

    authors： Rabelink NM,Lips P,Castelijns JA

    更新日期：2012-12-01 00:00:00

  • Radiotherapy in paediatric Cushing's disease: efficacy and long term follow up of pituitary function.

    abstract：:Pituitary radiotherapy (RT) is an effective second-line treatment for paediatric Cushing's disease (CD). We report long-term efficacy and anterior pituitary function in a cohort of paediatric CD patients treated with RT. Between 1988 and 2008, from our cohort of 48 paediatric CD patients, eight paediatric CD patients ...

    journal_title：Pituitary

    pub_type： 杂志文章

    doi：10.1007/s11102-010-0231-x

    authors： Acharya SV,Gopal RA,Goerge J,Menon PS,Bandgar TR,Shah NS

    更新日期：2010-12-01 00:00:00

  • Pituitary stem cells: candidates and implications.

    abstract：:The pituitary is the master endocrine gland of the body. It undergoes many changes after birth, and these changes may be mediated by the differentiation of pituitary stem cells. Stem cells in any tissue source must display (1) pluripotent capacity, (2) capacity for indefinite self-renewal, and (3) a lack of specializa...

    journal_title：Pituitary

    pub_type： 杂志文章,评审

    doi：10.1007/s11102-013-0470-8

    authors： Nassiri F,Cusimano M,Zuccato JA,Mohammed S,Rotondo F,Horvath E,Syro LV,Kovacs K,Lloyd RV

    更新日期：2013-09-01 00:00:00

  • Traumatic brain injury induced neuroendocrine changes: acute hormonal changes of anterior pituitary function.

    abstract：PURPOSE:It is estimated that approximately 69 million individuals worldwide will sustain a TBI each year, which accounts for substantial morbidity and mortality in both children and adults. TBI may lead to significant neuroendocrine changes, if the delicate pituitary is ruptured. In this review, we focus on the anterio...

    journal_title：Pituitary

    pub_type： 杂志文章,评审

    doi：10.1007/s11102-019-00944-0

    authors： Ntali G,Tsagarakis S

    更新日期：2019-06-01 00:00:00

  • Roles of insulin-like growth factor-I and growth hormone in mediating insulin resistance in acromegaly.

    abstract：:Most patients with acromegaly have some degree of insulin resistance. The principal mediator of insulin resistance in acromegaly is hypersecretion of growth hormone. Growth hormone acts at several levels to block insulin actions including inhibiting phosphorylation of the insulin receptor and one of its principal sign...

    journal_title：Pituitary

    pub_type： 杂志文章,评审

    doi：10.1023/a:1023321421760

    authors： Clemmons DR

    更新日期：2002-01-01 00:00:00

  • Management of recurrent pituitary cysts with pituitary-nasal drain.

    abstract：:Pituitary cysts are usually craniopharyngiomas or remnants of Rathke's cleft. Histologically craniopharyngiomas are lined by stratified squamous epithelium whereas Rathke's cleft cysts are lined by cuboidal or columnar epithelium. The management of pituitary cysts remains difficult because of the risks associated with...

    journal_title：Pituitary

    pub_type： 杂志文章

    doi：10.1023/a:1025373715860

    authors： Dashora U,Mathias D,James A,Zammit-Maempel I,Perros P

    更新日期：2002-01-01 00:00:00

  • Minor tumour shrinkage in nonfunctioning pituitary adenomas by long-term treatment with the dopamine agonist cabergoline.

    abstract：OBJECTIVE:The purpose of this study was to define safety and efficacy of medical therapy in the treatment of nonfunctioning pituitary tumours. DESIGN:We studied thirteen patients with a clinically nonfunctioning pituitary macroadenoma for response to cabergoline treatment for 1 year. Twelve/13 patients were already op...

    journal_title：Pituitary

    pub_type： 临床试验,杂志文章

    doi：10.1023/a:1015366923810

    authors： Lohmann T,Trantakis C,Biesold M,Prothmann S,Guenzel S,Schober R,Paschke R

    更新日期：2001-08-01 00:00:00

  • GH deficiency in cancer survivors in the transition age: diagnosis and therapy.

    abstract：BACKGROUND:Survival rates among childhood cancer survivors (CCSs) have significantly risen in the last 40 years due to substantial improvements in treatment protocols. However, this improvement has brought with it serious late effects that frequently involve the endocrine system. Of the endocrine disorders, GH deficien...

    journal_title：Pituitary

    pub_type： 杂志文章,评审

    doi：10.1007/s11102-020-01052-0

    authors： Sbardella E,Crocco M,Feola T,Papa F,Puliani G,Gianfrilli D,Isidori AM,Grossman AB

    更新日期：2020-08-01 00:00:00

  • Staging and managing patients with acromegaly in clinical practice: baseline data from the SAGIT® validation study.

    abstract：PURPOSE:The SAGIT® instrument, designed to assist clinicians to stage acromegaly, assess treatment response and adapt patient management, was well received by endocrinologists in a pilot study. We report an interim analysis of baseline data from the validation phase. METHODS:The SAGIT® validation study (ClinicalTrials...

    journal_title：Pituitary

    pub_type： 杂志文章

    doi：10.1007/s11102-019-00977-5

    authors： Giustina A,Bronstein MD,Chanson P,Petersenn S,Casanueva FF,Sert C,Houchard A,Melmed S

    更新日期：2019-10-01 00:00:00

  • Defining normalcy of the somatotropic axis: an attainable goal?

    abstract：:The diagnoses of acromegaly and dwarfism require biochemical confirmation of abnormal GH and IGF-1 concentrations. The same parameters are used for therapeutic decisions, i.e. initiation or termination of particular treatments. Therefore, reliable and epidemiologically and statistically proven criteria of normalcy for...

    journal_title：Pituitary

    pub_type： 杂志文章,评审

    doi：10.1007/s11102-007-0029-7

    authors： Barkan AL

    更新日期：2007-01-01 00:00:00

  • A prospective longitudinal study of Pasireotide in Nelson's syndrome.

    abstract：PURPOSE:Nelson's syndrome is a challenging condition that can develop following bilateral adrenalectomy for Cushing's disease, with high circulating ACTH levels, pigmentation and an invasive pituitary tumor. There is no established medical therapy. The aim of the study was to assess the effects of pasireotide on plasma...

    journal_title：Pituitary

    pub_type： 杂志文章

    doi：10.1007/s11102-017-0853-3

    authors： Daniel E,Debono M,Caunt S,Girio-Fragkoulakis C,Walters SJ,Akker SA,Grossman AB,Trainer PJ,Newell-Price J

    更新日期：2018-06-01 00:00:00

  • Predictors of endoscopic transsphenoidal surgery outcome in acromegaly: patient and tumor characteristics evaluated by magnetic resonance imaging.

    abstract：:The availability of various first-line treatment modalities for acromegaly and evolving surgical techniques emphasize the need for accurately defined predictors of surgical outcome. We retrospectively analysed the outcome of 30 patients with acromegaly after initial endoscopic transsphenoidal surgery in two university...

    journal_title：Pituitary

    pub_type： 杂志文章

    doi：10.1007/s11102-012-0395-7

    authors： van Bunderen CC,van Varsseveld NC,Baayen JC,van Furth WR,Aliaga ES,Hazewinkel MJ,Majoie CB,Freling NJ,Lips P,Fliers E,Bisschop PH,Drent ML

    更新日期：2013-06-01 00:00:00

  • Xanthomatous pituitary lesions: a report of two cases and review of the literature.

    abstract：:We describe two young men with cystic pituitary enlargement on magnetic resonance imaging (MRI) causing hypopituitarism. The first patient presented acutely unwell with headache and vomiting associated with anterior and posterior pituitary dysfunction. The second patient presented with hypopituitarism after a long his...

    journal_title：Pituitary

    pub_type： 杂志文章,评审

    doi：10.1023/b:pitu.0000011177.43408.56

    authors： Burt MG,Morey AL,Turner JJ,Pell M,Sheehy JP,Ho KK

    更新日期：2003-01-01 00:00:00

  • Sellar collision tumor involving pituitary gonadotroph adenoma and chondroma: a potential clinical diagnosis.

    abstract：:We report on a 74-year-old male patient who presented with progressive neuroophthalmologic symptoms soon after the administration of a long-acting gonadotropin-releasing hormone agonist for treatment of a prostate cancer. Imaging revealed a destructively growing and extensively calcified sellar mass inconsistent with ...

    journal_title：Pituitary

    pub_type： 杂志文章

    doi：10.1007/s11102-009-0199-6

    authors： Sahli R,Christ E,Kuhlen D,Giger O,Vajtai I

    更新日期：2011-12-01 00:00:00

  • "Micromegaly": an update on the prevalence of acromegaly with apparently normal GH secretion in the modern era.

    abstract：PURPOSE:Approximately 25 % of cases of clinically active acromegaly cases treated in our academic center between 1996 and 2000, were diagnosed in patients who had elevated plasma IGF-1 levels, but apparently "normal" 24-h mean plasma GH levels. The current study served to update the data for patients with acromegaly re...

    journal_title：Pituitary

    pub_type： 杂志文章

    doi：10.1007/s11102-016-0735-0

    authors： Butz LB,Sullivan SE,Chandler WF,Barkan AL

    更新日期：2016-12-01 00:00:00

  • Prevalence of hematological abnormalities in patients with Sheehan's syndrome: response to replacement of glucocorticoids and thyroxine.

    abstract：:Anemia and other hematological abnormalities are common in patients with Sheehan's syndrome. The response of these abnormalities to replacement of thyroxine and glucocorticoids is not clear. The aim of the present study was to document the profile of hematological abnormalities and response to treatment in patients wi...

    journal_title：Pituitary

    pub_type： 杂志文章

    doi：10.1007/s11102-010-0255-2

    authors： Laway BA,Mir SA,Bashir MI,Bhat JR,Samoon J,Zargar AH

    更新日期：2011-03-01 00:00:00